BENDHEIM JACK bought PAHC

September 19, 2025 · Form 4 insider transaction

BENDHEIM JACK bought 30,000 shares of Phibro Animal Health Corporation at $0.00 per share, a transaction worth N/A. The trade was recorded as conversion of a derivative and disclosed on an SEC Form 4, filed 3 days after the transaction.

Direction
Acquired (buy-side)
Shares
30,000
Price
$0.00
Total value
N/A
Role
SecurityClass A Common Stock
Transaction codeC: Conversion of a derivative
Transaction dateSeptember 19, 2025
Filing dateSeptember 22, 2025
Shares owned after61,338
OwnershipIndirect
10b5-1 planNo
AmendedNo

Footnotes

Class B Common Stock is convertible into Class A Common Stock at any time on a one-for-one basis, at the holder's election, and has no expiration date.; The reported securities are directly held by BFI. Jack Bendheim, a reporting person, director and officer of the Issuer, exercises voting and dispositive power over BFI and may be deemed to have shared voting and investment power over the securities held by BFI. Mr. Bendheim disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein.

View the original Form 4 on SEC EDGAR
BENDHEIM JACK bought PAHC: September 19, 2025 | Insider Trading Screener